drugset / Trial / NCT01945099

Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy

NCT01945099

Phase 0 Completed 13 enrolled Yale University
Non-randomizedCrossoverOpen-labelTreatment

Summary

"Closed loop artificial pancreas" systems have been under development for the control of blood sugars in those living with diabetes. These systems consist of a continuous glucose sensor, which sends a signal to a computer program that automatically determines how much insulin to give. The computer program then tells an insulin pump to deliver the insulin. While such systems have been tested under a number of conditions, post-meal blood sugars are difficult to control. Specifically, we will be looking to see if using hyaluronidase improves the ability of the closed loop artificial pancreas to better respond to meal related highs and lows.

Timeline

Start
2013-09
Primary completion
2015-12
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lispro-PH20 Unknown Subcutaneous
Subject rHuPH20 Protein / enzyme biologic Subcutaneous